NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Visionary Holdings Inc. (NASDAQ:GV) ("GV" or the "Company"), a ...

Pancreatic cancer has the highest mortality rate of all major cancers, and its incidence is climbing. Because it is typically ...

A team led by researchers at the Keck School of Medicine of USC has developed advanced synthetic kidney structures that ...

The new application relates to how Akari’s novel PH1 payload demonstrates its ability to modulate the spliceosome to disrupt ...

Investing.com -- Visionary Education Technology Holdings Group Inc (NASDAQ:GV) stock surged 76.4% Wednesday after the company announced a strategic partnership with Jiangsu Yike Regenerative Medicine, ...

Radiance Technologies (Radiance), an employee-owned leader in defense and intelligence solutions, has been awarded a prime Other Transaction (OT) contract valued up to $5.85 million over 18 months by ...

NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity CLIA-certified and CAP-accredited clinical laboratory, today ...

The iPhone Air introduces a global shift to eSIM-only connectivity, ditching the physical SIM card tray. This sleek device, ...

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

“This new facility is built for scale, speed, and global impact,” said Enn Õunpuu, CEO of Elcogen. “As demand for reliable Solid Oxide-based clean energy solutions accelerates worldwide, Elcogen is ...

Visionary Holdings (GV) entered into a strategic partnership with Jiangsu Yike Regenerative Medicine. The two parties will combine their respective strengths to collaborate on research, development, ...